This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

IsoRay (ISR) Rallies Ahead of Major Conference

NEW YORK (TheStreet) -- IsoRay (ISR - Get Report) is rallying on Tuesday ahead of its participation in a major medical conference toward the end of the week.

By midmorning, shares had soared 18.2% to $2.60.

Trading volume of 14.2 million exceeded its three-month daily average of 11.7 million.

Earlier, the radioisotope specialist announced it would host a booth at the Annual Meeting of the American Brachytherapy Society (ABS), a conference held in San Diego from April 3 to 5.

Must Read: Why Ku6 Media (KUTV) Shares Are Surging Today

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

IsoRay's Cesium-131 will be featured in five separate panels where specialists, including the University of Pittsburgh Medical Center's Dr. Ron Benoit, Dr. Sushil Beriwal and Dr. Ryan P. Smith, will discuss their experience using the treatment.

"Management believes that all studies will show exceptional results realized in all areas of the body where Cesium-131, or the physics associated with Cesium-131, was used," said CEO Dwight Babcock in a statement.

"With the ongoing publication of positive study results like these, the medical community is becoming increasingly aware of the innovative alternative our Cesium-131 products offer to cancer patients," he continued.

Cesium-131 seeds, sutured seeds, stranded mesh or IsoRay's GliaSite radiation therapy system allows physicians to concentrate radiation in required areas, meaning the treatment is less likely to damage surrounding healthy tissue.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
ISR $1.43 -1.40%
AAPL $110.51 -1.60%
FB $88.17 -1.90%
GOOG $605.84 -1.40%
TSLA $245.72 -0.80%

Markets

Chart of I:DJI
DOW 16,374.76 +23.38 0.14%
S&P 500 1,951.13 +2.27 0.12%
NASDAQ 4,733.4970 -16.4820 -0.35%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs